Dr. Tanya B. Dorff, MD | Duarte, CA ...

Dr. Tanya Dorff, MD

Claim this profile

City of Hope Medical Center

Expert in Prostate Cancer
Studies Prostate Adenocarcinoma
15 reported clinical trials
37 drugs studied

Area of expertise

1

Prostate Cancer

Global Leader

Tanya Dorff, MD has run 13 trials for Prostate Cancer. Some of their research focus areas include:

Stage IV
PSCA positive
PSA positive
2

Prostate Adenocarcinoma

Tanya Dorff, MD has run 2 trials for Prostate Adenocarcinoma. Some of their research focus areas include:

Stage IV

Affiliated Hospitals

Image of trial facility.

City Of Hope Medical Center

Image of trial facility.

City Of Hope

Clinical Trials Tanya Dorff, MD is currently running

Image of trial facility.

Standard Therapy + Surgery/Radiation

for Prostate Cancer

This phase III trial studies how well standard systemic therapy with or without definitive treatment (prostate removal surgery or radiation therapy) works in treating participants with prostate cancer that has spread to other places in the body. Addition of prostate removal surgery or radiation therapy to standard systemic therapy for prostate cancer may lower the chance of the cancer growing or spreading.

Recruiting

2 awards

Phase 3

30 criteria

Image of trial facility.

Microbiome Changes

for Prostate Cancer

This study collects urine and stool samples to determine the ability to identify changes in the microbiome (bacteria, fungi, and viruses that live in the gut and urine) of patients with prostate cancer during androgen deprivation therapy and radiation therapy. Radiation therapy has the potential to harm the genitourinary area or the bowel, causing a feeling of urgency or increased inflammation in the area. The radiation therapy is designed to not irradiate the bowel and bladder areas, but there is still some radiation exposure. The gut microbiome has been associated with differences in inflammation as well as producing molecules that influence healing. The purpose of this study is to see whether the microbiome may contribute to the healing of the organs exposed to radiation. Information learned from this study may help researchers discover a new risk factor that could be manipulated to improve the quality of life in patients with prostate cancer.

Recruiting

1 award

N/A

6 criteria

More about Tanya Dorff, MD

Clinical Trial Related

9 years of experience running clinical trials · Led 15 trials as a Principal Investigator · 5 Active Clinical Trials

Treatments Tanya Dorff, MD has experience with

  • Abiraterone Acetate
  • Prednisone
  • Apalutamide
  • Degarelix
  • Bicalutamide
  • Triptorelin

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Tanya Dorff, MD specialize in?

Is Tanya Dorff, MD currently recruiting for clinical trials?

Are there any treatments that Tanya Dorff, MD has studied deeply?

What is the best way to schedule an appointment with Tanya Dorff, MD?

What is the office address of Tanya Dorff, MD?

Is there any support for travel costs?